Effect of improved systemic therapy on patient survival in metastatic non‐clear‐cell renal cell carcinoma
Hiroki Ishihara, Hidekazu Tachibana, Toshio Takagi, Kazuhiko Yoshida, Tsunenori Kondo, Kazunari Tanabe
Abstract
Table S1. Objective response rates of first-line and nivolumab therapy. Table S2. Characteristics of metastatic non-clear-cell RCC patients according to time periods. Table S3. Univariate and multivariate analyses for OS in metastatic non-clear-cell RCC patients. Table S4. Systemic therapy profile according to time periods. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Topics & Concepts
MedicineRenal cell carcinomaSystemic therapyNivolumabUnivariateOncologyTable (database)Internal medicineMultivariate analysisUnivariate analysisMultivariate statisticsCancerImmunotherapyDatabaseStatisticsComputer scienceBreast cancerMathematicsRenal cell carcinoma treatmentRenal and related cancersPancreatic and Hepatic Oncology Research